StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Q1

<< Previous

Bullboard Posts

Next >>

Comment by Jonnyboy85on May 13, 2022 10:32am

100 Views

Post# 34681351

RE:Q1

Thanks for sharing, there's been so little news this place has been a ghost town lately. I miss the days when we had 5 or 10 good diggers here and there was so much data to got through. Hopefully this quarterly will have lots and more news to come for the summer for us patient longs.

Nailbiter1 wrote:
TORONTO, ON / ACCESSWIRE / May 13, 2022 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS) today announced that it will release its first quarter financial results before the market open on Tuesday May 17, 2022. StageZero's Chairman and CEO, James Howard-Tripp, will host a conference call and accompanying webcast at 8:30 a.m. EDT on Tuesday May 17, 2022, to review the operational results and discuss business developments.

Analyst and Investor Call

Event Date: Tuesday May 17, 2022
Time: 8:30 a.m. EST
Webcast Link: https://www.webcaster4.com/Webcast/Page/2082/45520
Participant Numbers: Toll Free: +1-877-545-0523
International: +1-973-528-0016
Participant Access Code: 770603

Replay Number: Toll Free: +1-877-481-4010
International: +1-919-882-2331]
Replay Passcode: 45520